The DNA testing company 23andMe has gotten FDA approval to screen for 3 BRCA gene mutations linked to a higher risk of breast cancer. But the test raises some concerns. Katie Nielsen of CBS San Francisco station KPIX reports.

Advertisement
Code: bgsport. 15% OFF for Sports & Outdoor Products

More videos

20180622 061
Ruptly TV 22 Jun 2018 21:00 CEST

20180622 061